The global pharmaceutical industry is witnessing a paradigm shift, with the generic injectables market emerging as a critical driver of equitable healthcare access. As governments, hospitals, and patients grapple with escalating medical costs, generic injectables—bioequivalent to branded counterparts but priced significantly lower—are gaining momentum. These products, spanning...